Huntington's disease trials in Norway

2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

  Where

  Oslo

  Age

  21 years to 70 years

  People

  770 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT07326709 · EU 2025-522227-99-00
• Phase 2Taking people
  The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease

  Where

  Oslo

  Age

  18 years to 80 years

  People

  120

  Run by

  Oslo University Hospital

  See details and how to joinNCT06853743